CY1121912T1 - Βιοαποικοδομησιμο οφθαλμικο εμφυτευμα - Google Patents

Βιοαποικοδομησιμο οφθαλμικο εμφυτευμα

Info

Publication number
CY1121912T1
CY1121912T1 CY20191100865T CY191100865T CY1121912T1 CY 1121912 T1 CY1121912 T1 CY 1121912T1 CY 20191100865 T CY20191100865 T CY 20191100865T CY 191100865 T CY191100865 T CY 191100865T CY 1121912 T1 CY1121912 T1 CY 1121912T1
Authority
CY
Cyprus
Prior art keywords
eye implant
ocular region
implants
biodegradable
biodegradable eye
Prior art date
Application number
CY20191100865T
Other languages
English (en)
Inventor
David Weber
David Chou
Lin Peng
Thierry Nivaggioli
Original Assignee
Allergan, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan, Inc. filed Critical Allergan, Inc.
Publication of CY1121912T1 publication Critical patent/CY1121912T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

Η εφεύρεση παρέχει βιοαποικοδομήσιμα εμφυτεύματα καταλλήλου μεγέθους για εμφύτευση εντός μίας οφθαλμικής περιοχής και μεθόδους για την αγωγή ιατρικών καταστάσεων του οφθαλμού. Τα εμφυτεύματα σχηματίζονται από ένα μίγμα PLGA με υδρόφιλο άκρο και υδρόφοβο άκρο και χορηγούν δραστικούς παράγοντες εντός μίας οφθαλμικής περιοχής χωρίς υψηλή έκρηξη αποδέσμευσης.
CY20191100865T 2003-01-09 2019-08-13 Βιοαποικοδομησιμο οφθαλμικο εμφυτευμα CY1121912T1 (el)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10/340,237 US20040137059A1 (en) 2003-01-09 2003-01-09 Biodegradable ocular implant
PCT/US2004/000351 WO2004062649A2 (en) 2003-01-09 2004-01-07 Biodegradable ocular implant
EP14165593.6A EP2799064B1 (en) 2003-01-09 2004-01-07 Biodegradable ocular implant
EP04700611A EP1581193B1 (en) 2003-01-09 2004-01-07 Biodegradable ocular implant
EP08002892.1A EP1917957B1 (en) 2003-01-09 2004-01-07 Biodegradable ocular implant

Publications (1)

Publication Number Publication Date
CY1121912T1 true CY1121912T1 (el) 2020-10-14

Family

ID=32711277

Family Applications (4)

Application Number Title Priority Date Filing Date
CY20171100057T CY1118431T1 (el) 2003-01-09 2017-01-17 Βιοαποικοδομησιμο οφθαλμικο εμφυτευμα
CY20181100250T CY1120147T1 (el) 2003-01-09 2018-02-28 Βιοαποικοδομησιμο οφθαλμικο εμφυτευμα
CY20191100615T CY1121731T1 (el) 2003-01-09 2019-06-13 Βιοαποικοδομησιμο οφθαλμικο εμφυτευμα
CY20191100865T CY1121912T1 (el) 2003-01-09 2019-08-13 Βιοαποικοδομησιμο οφθαλμικο εμφυτευμα

Family Applications Before (3)

Application Number Title Priority Date Filing Date
CY20171100057T CY1118431T1 (el) 2003-01-09 2017-01-17 Βιοαποικοδομησιμο οφθαλμικο εμφυτευμα
CY20181100250T CY1120147T1 (el) 2003-01-09 2018-02-28 Βιοαποικοδομησιμο οφθαλμικο εμφυτευμα
CY20191100615T CY1121731T1 (el) 2003-01-09 2019-06-13 Βιοαποικοδομησιμο οφθαλμικο εμφυτευμα

Country Status (21)

Country Link
US (1) US20040137059A1 (el)
EP (6) EP3187177B1 (el)
JP (1) JP4223040B2 (el)
KR (1) KR20050099008A (el)
CN (2) CN101259280A (el)
AT (1) ATE555779T1 (el)
AU (1) AU2004204744B2 (el)
BR (2) BR122015016901B8 (el)
CA (1) CA2512315C (el)
CY (4) CY1118431T1 (el)
DK (5) DK1917957T3 (el)
ES (5) ES2661383T3 (el)
FR (1) FR12C0067I1 (el)
HK (1) HK1084021A1 (el)
HU (4) HUE036209T2 (el)
MX (1) MXPA05007342A (el)
NZ (1) NZ540451A (el)
PT (4) PT1917957T (el)
SI (3) SI2799064T1 (el)
TR (2) TR201908857T4 (el)
WO (1) WO2004062649A2 (el)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US20060280774A1 (en) * 1995-06-02 2006-12-14 Allergan, Inc. Compositions and methods for treating glaucoma
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
ES2250504T3 (es) 2000-11-29 2006-04-16 Allergan Inc. Prevencion del rechazo de injerto en el ojo.
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
US20130041025A1 (en) 2002-02-04 2013-02-14 Allergan, Inc. Compositions and methods for treating hair loss, hair thinning, and hair color loss
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
US8246974B2 (en) 2003-05-02 2012-08-21 Surmodics, Inc. Medical devices and methods for producing the same
US8021680B2 (en) 2003-05-02 2011-09-20 Surmodics, Inc. Controlled release bioactive agent delivery device
US7060723B2 (en) 2003-08-29 2006-06-13 Allergan, Inc. Treating neurological disorders using selective antagonists of persistent sodium current
US7125908B2 (en) * 2003-08-29 2006-10-24 Allergan, Inc. Treating pain using selective antagonists of persistent sodium current
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
AU2005209201B2 (en) 2004-01-20 2010-06-03 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
WO2005110374A1 (en) * 2004-04-30 2005-11-24 Allergan, Inc. Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US20050244466A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Photodynamic therapy in conjunction with intraocular implants
US8685435B2 (en) 2004-04-30 2014-04-01 Allergan, Inc. Extended release biodegradable ocular implants
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US20050244469A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US8425929B2 (en) * 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
US8673341B2 (en) 2004-04-30 2014-03-18 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
US20050244461A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Controlled release drug delivery systems and methods for treatment of an eye
US20050244458A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular neuropathies
JP2008523101A (ja) * 2004-12-10 2008-07-03 タリマ セラピューティクス， インコーポレイテッド 爪ユニットの状態を治療するための組成物および方法
US20060275230A1 (en) * 2004-12-10 2006-12-07 Frank Kochinke Compositions and methods for treating conditions of the nail unit
US20060204548A1 (en) * 2005-03-01 2006-09-14 Allergan, Inc. Microimplants for ocular administration
AU2011236024B2 (en) * 2005-03-01 2013-05-23 Allergan, Inc. Microimplants for ocular administration
US20090082321A1 (en) * 2007-09-21 2009-03-26 Allergan, Inc. Steroid containing drug delivery systems
US20070178138A1 (en) * 2006-02-01 2007-08-02 Allergan, Inc. Biodegradable non-opthalmic implants and related methods
US20070260203A1 (en) * 2006-05-04 2007-11-08 Allergan, Inc. Vasoactive agent intraocular implant
US8802128B2 (en) * 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
EP1917971A1 (en) * 2006-10-27 2008-05-07 Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) Substained release formulations comprising very low molecular weight polymers
US8969415B2 (en) * 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
US8536190B2 (en) * 2007-01-30 2013-09-17 Allergan, Inc. Treating unwanted ocular conditions using an ascomycin macrolactam
CA2680831A1 (en) * 2007-03-14 2008-09-18 University Of Washington Device and method for intraocular drug delivery
US20080317805A1 (en) * 2007-06-19 2008-12-25 Mckay William F Locally administrated low doses of corticosteroids
RU2478366C2 (ru) * 2007-09-07 2013-04-10 Клт Инк. Лекарственные ядра для замедленного высвобождения терапевтических средств
US8353862B2 (en) 2007-11-02 2013-01-15 Allergan, Inc. Drug delivery systems and methods
US8524267B2 (en) * 2008-04-18 2013-09-03 Warsaw Orthopedic, Inc. Dexamethasone formulations in a biodegradable material
US9125917B2 (en) * 2008-04-18 2015-09-08 Warsaw Orthopedic, Inc. Fluocinolone formulations in a biodegradable polymer carrier
US10064819B2 (en) 2008-05-12 2018-09-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9095404B2 (en) 2008-05-12 2015-08-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
JP5591226B2 (ja) 2008-05-12 2014-09-17 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション 眼内薬物送達装置および関連する方法
US10588855B2 (en) 2008-05-12 2020-03-17 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US20110206773A1 (en) * 2008-05-20 2011-08-25 Yale University Sustained delivery of drugs from biodegradable polymeric microparticles
WO2009143288A1 (en) * 2008-05-20 2009-11-26 Yale University Biodegradable sustained-release polymeric microparticulates comprising a hydrophobic drug and determined for ophthalmic use
CN101612111B (zh) * 2008-06-24 2011-11-23 上海医药工业研究院 醋酸诺美孕酮或其类似物的缓释微球及其制备方法和用途
US20110125090A1 (en) * 2008-11-13 2011-05-26 Peyman Gholam A Ophthalmic drug delivery system and method
US10272035B2 (en) 2008-11-13 2019-04-30 Gholam A. Peyman Ophthalmic drug delivery method
US10842669B2 (en) 2008-11-13 2020-11-24 Gholam A. Peyman Ophthalmic drug delivery method
US20100204325A1 (en) * 2009-02-11 2010-08-12 Allergan, Inc. Valproic acid drug delivery systems and intraocular therapeutic uses thereof
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US20100303757A1 (en) 2009-05-29 2010-12-02 Allergan, Inc. Methods of Treating Chronic Neurogenic Inflammation Using Interleukin Retargeted Endopepidases
US20100303794A1 (en) 2009-05-29 2010-12-02 Allergan, Inc. Methods of Treating Urogenital-Neurological Disorders Using Glucagon Like Hormone Retargeted Endopepidases
US20100303788A1 (en) * 2009-05-29 2010-12-02 Allergan, Inc. Methods of Treating Chronic Neurogenic Inflammation Using Galanin Retargeted Endopepidases
US20100303783A1 (en) * 2009-05-29 2010-12-02 Allergan, Inc. Methods of Treating Urogenital-Neurological Disorders Using Tachykinin Retargeted Endopepidases
KR20120061879A (ko) 2009-08-14 2012-06-13 알러간, 인코포레이티드 뉴로트로핀 재표적화된 엔도펩티다아제를 사용하여 암을 치료하는 방법
KR20120107926A (ko) 2009-08-14 2012-10-04 알러간, 인코포레이티드 오피오이드 재표적화된 엔드펩티다아제를 사용하여 암을 치료하는 방법
CN102573875A (zh) 2009-08-14 2012-07-11 阿勒根公司 使用速激肽再靶向内肽酶治疗癌症的方法
WO2011020119A2 (en) 2009-08-14 2011-02-17 Allergan, Inc. Methods of treating cancer using glucagon-like hormone retargeted endopeptidases
US20110070186A1 (en) 2009-08-14 2011-03-24 Allergan, Inc. Methods of Treating Cancer Using Growth Factor Retargeted Endopeptidases
US20110070211A1 (en) * 2009-08-14 2011-03-24 Allergan, Inc. Methods of Treating Cancer Using Galanin Retargeted Endopepidases
EP2957560B1 (en) 2010-02-08 2017-08-02 Allergan, Inc. Pyridazine derivatives useful as cannabinoid-2 agonists
US8349005B2 (en) 2011-01-03 2013-01-08 Masatoshi Murata Method for burying implant to choroid
WO2012112422A1 (en) 2011-02-14 2012-08-23 Allergan, Inc. Inhibiting aberrant blood vessel formation using growth factor retargeted endopeptidases
US20120207743A1 (en) 2011-02-14 2012-08-16 Allergan, Inc. Inhibiting Aberrant Blood Vessel Formation Using Retargeted Endopeptidases
WO2012112426A1 (en) 2011-02-14 2012-08-23 Allergan, Inc. Arginine vasopressin retargeted clostridial endopeptidases for use in treating benign prostatic hyperplasia
WO2012112432A1 (en) 2011-02-14 2012-08-23 Allergan, Inc. Methods of inhibiting aberrant blood vessel formation using opioid retargeted endopeptidases
WO2012112420A1 (en) 2011-02-14 2012-08-23 Allergan, Inc. Treatments using psma ligand endopeptidases
US10245178B1 (en) 2011-06-07 2019-04-02 Glaukos Corporation Anterior chamber drug-eluting ocular implant
JP6549482B2 (ja) 2012-06-01 2019-07-24 サーモディクス，インコーポレイテッド バルーンカテーテルをコーティングするための装置および方法
US9827401B2 (en) 2012-06-01 2017-11-28 Surmodics, Inc. Apparatus and methods for coating medical devices
WO2014066644A1 (en) 2012-10-26 2014-05-01 Allergan, Inc. Ketorolac-containing sustained release drug delivery systems
CA2897197C (en) * 2013-01-15 2022-06-07 The Regents Of The University Of Colorado, A Body Corporate Lacrimal system drug delivery device
CA2904703A1 (en) 2013-03-14 2014-10-02 Hallux, Inc. Method of treating infections, diseases or disorders of nail unit
ES2805880T3 (es) * 2013-10-31 2021-02-15 Allergan Inc Implantes intraoculares que contienen prostamida y métodos de uso de éstos
CA2939651A1 (en) * 2014-02-26 2015-09-03 Allergan, Inc. Intraocular implant delivery apparatus and methods of use thereof
JP6655610B2 (ja) 2014-05-29 2020-02-26 グローコス コーポレーション 制御された薬物送達機能を備えるインプラント及びそれを使用する方法
CN106687080A (zh) 2014-09-11 2017-05-17 普西维达公司 注射器设备
FR3028410A1 (fr) 2014-11-18 2016-05-20 Pierre Coulon Implant capsulaire multifonctionnel
WO2017040853A1 (en) 2015-09-02 2017-03-09 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
US11564833B2 (en) 2015-09-25 2023-01-31 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
USD851755S1 (en) 2015-10-22 2019-06-18 Eyepoint Pharmaceuticals Us, Inc. Ocular inserter
CA3006042A1 (en) 2015-11-23 2017-06-01 The Regents Of The University Of Colorado, A Body Corporate Lacrimal system for drug delivery
EP3442479A1 (en) 2016-04-20 2019-02-20 Harold Alexander Heitzmann Bioresorbable ocular drug delivery device
EP3458030B1 (en) 2016-05-20 2021-05-12 The Regents of The University of Colorado, A Body Corporate Lacrimal drug delivery device
US11628466B2 (en) 2018-11-29 2023-04-18 Surmodics, Inc. Apparatus and methods for coating medical devices
US11819590B2 (en) 2019-05-13 2023-11-21 Surmodics, Inc. Apparatus and methods for coating medical devices
US20210060316A1 (en) * 2019-08-30 2021-03-04 Intersect Ent, Inc. Submucosal bioresorbable drug eluting platform

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322323A (en) * 1980-12-01 1982-03-30 Alza Corporation Erodible device comprising surfactant for modifying the rate of erosion of the device
EP0052916B1 (en) * 1980-11-10 1985-01-02 Alza Corporation Erodible polymer containing erosion rate modifier
US4883457A (en) * 1983-08-18 1989-11-28 Drug Delivery Systems Inc. Disposable and/or replenishable transdermal drug applicators and methods of manufacturing same
US6217911B1 (en) * 1995-05-22 2001-04-17 The United States Of America As Represented By The Secretary Of The Army sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
US6309669B1 (en) * 1984-03-16 2001-10-30 The United States Of America As Represented By The Secretary Of The Army Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
US4863457A (en) 1986-11-24 1989-09-05 Lee David A Drug delivery device
JPS63291419A (ja) * 1987-05-24 1988-11-29 Tatsumo Kk 加熱処理装置
US4997652A (en) * 1987-12-22 1991-03-05 Visionex Biodegradable ocular implants
US4853224A (en) * 1987-12-22 1989-08-01 Visionex Biodegradable ocular implants
US5164188A (en) * 1989-11-22 1992-11-17 Visionex, Inc. Biodegradable ocular implants
KR0185215B1 (ko) * 1990-11-30 1999-05-01 요시다 쇼오지 서방성 안구삽입용 약제
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
DE69425411T2 (de) 1993-02-26 2001-02-08 Santen Pharmaceutical Co., Ltd Biologisch abbaubarer sklerastopfen
US5707643A (en) * 1993-02-26 1998-01-13 Santen Pharmaceutical Co., Ltd. Biodegradable scleral plug
US5443505A (en) * 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
US6369116B1 (en) * 1995-06-02 2002-04-09 Oculex Pharmaceuticals, Inc. Composition and method for treating glaucoma
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
WO1997026869A1 (en) * 1996-01-24 1997-07-31 United States Government Represented By The Secretary Of The Army Novel 'burst-free' sustained release poly-(lactide/glycolide) microspheres
EP0992244A4 (en) * 1997-07-02 2001-01-17 Santen Pharmaceutical Co Ltd SCLERAL PLUGS OF POLYLACTIC ACID
US6306426B1 (en) * 1997-08-11 2001-10-23 Allergan Sales, Inc. Implant device with a retinoid for improved biocompatibility
US6217895B1 (en) * 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6726918B1 (en) * 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
ES2250504T3 (es) * 2000-11-29 2006-04-16 Allergan Inc. Prevencion del rechazo de injerto en el ojo.

Also Published As

Publication number Publication date
BR122015016901B1 (pt) 2018-06-05
SI2799064T1 (en) 2018-04-30
EP3305284B1 (en) 2019-05-15
AU2004204744B2 (en) 2008-03-13
EP3563839A1 (en) 2019-11-06
EP3187177B1 (en) 2019-03-20
JP2006525953A (ja) 2006-11-16
CY1118431T1 (el) 2017-06-28
EP1581193B1 (en) 2012-05-02
ES2613028T3 (es) 2017-05-22
ES2735132T3 (es) 2019-12-16
NZ540451A (en) 2008-02-29
HUE044965T2 (hu) 2019-11-28
DK3187177T3 (da) 2019-06-24
PT3305284T (pt) 2019-08-30
HUE030319T2 (en) 2017-05-29
DK1581193T3 (da) 2012-06-25
SI3187177T1 (sl) 2019-09-30
SI3305284T1 (sl) 2019-11-29
FR12C0067I1 (fr) 2012-12-14
CN100364514C (zh) 2008-01-30
ES2661383T3 (es) 2018-03-28
WO2004062649A3 (en) 2004-11-04
CA2512315C (en) 2008-12-30
CN101259280A (zh) 2008-09-10
EP3305284A1 (en) 2018-04-11
MXPA05007342A (es) 2005-09-30
JP4223040B2 (ja) 2009-02-12
BRPI0406692A (pt) 2005-12-20
HK1084021A1 (en) 2006-07-21
ES2742152T3 (es) 2020-02-13
PT1917957T (pt) 2017-01-23
PT3187177T (pt) 2019-06-27
EP1581193A2 (en) 2005-10-05
TR201908857T4 (tr) 2019-07-22
DK1917957T3 (en) 2017-02-13
HUE044694T2 (hu) 2019-11-28
CY1121731T1 (el) 2020-07-31
BR122015016901B8 (pt) 2021-07-27
EP1917957A3 (en) 2011-06-15
KR20050099008A (ko) 2005-10-12
AU2004204744A1 (en) 2004-07-29
EP2799064A1 (en) 2014-11-05
CN1735405A (zh) 2006-02-15
HUE036209T2 (hu) 2018-06-28
WO2004062649A2 (en) 2004-07-29
DK2799064T3 (en) 2018-03-12
EP1917957A2 (en) 2008-05-07
ES2384875T3 (es) 2012-07-13
EP1917957B1 (en) 2016-11-16
EP2799064B1 (en) 2017-11-29
CY1120147T1 (el) 2018-12-12
CA2512315A1 (en) 2004-07-29
EP3187177A1 (en) 2017-07-05
US20040137059A1 (en) 2004-07-15
TR201802793T4 (tr) 2018-03-21
PT2799064T (pt) 2018-03-06
ATE555779T1 (de) 2012-05-15
DK3305284T3 (da) 2019-08-19

Similar Documents

Publication Publication Date Title
CY1121912T1 (el) Βιοαποικοδομησιμο οφθαλμικο εμφυτευμα
TW200621263A (en) Ocular implant made by a double extrusion process
WO2010019507A3 (en) Implantable drug delivery device and methods of treating male genitourinary and surrounding tissues
WO2004087006A3 (en) Implant delivery technologies
WO2007076508A3 (en) Implantable graft material
AU3649502A (en) Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
ATE404140T1 (de) Vorrichtung zur intraokularen wirkstoffverabreichung
HK1059037A1 (en) Methods and compositions for treatment of ocular neovascularization and neural injury
MX2011008875A (es) Implantes lagrimales y metodos relacionados.
EP2772234A3 (en) Apparatus for creating ocular surgical and relaxing incisions
WO2004050140A3 (en) Medical devices for delivery of therapeutic agents
ATE446784T1 (de) Konfiguration implantierter vorrichtungen
WO2008098125A3 (en) Medical implants with pre-settled cores and related methods
CA2567140A1 (en) Methods and apparatus for delivery of ocular implants
Service et al. Alternative placement of the floating mass transducer in implanting the MED-EL Vibrant Soundbridge
AU2021903621A0 (en) An implant and surgical procedures for the implanting thereof
KR20200121564A (ko) 생체 삽입용 부재
DE60017933D1 (de) Element zur implantation in körpergewebe und gerät zu dessen herstellung